UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 337

Sortiert nach

What is CD4+CD56+ malignancy and how should it be treated?

Bone marrow transplantation (Basingstoke), 2003-10, Vol.32 (7), p.637-646

2003

Volltextzugriff (PDF)

BCL2 Expression Is a Prognostic Marker for the Activated B-Cell–Like Type of Diffuse Large B-Cell Lymphoma

Journal of clinical oncology, 2006-02, Vol.24 (6), p.961-968

2006

Volltextzugriff (PDF)

BCL2 Translocation Defines a Unique Tumor Subset within the Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma

The American journal of pathology, 2004-07, Vol.165 (1), p.159-166

2004

Volltextzugriff (PDF)

Classification of non-Hodgkin lymphoma in Central and South America: a review of 1028 cases

Blood, 2012-12, Vol.120 (24), p.4795-4801

2012

Volltextzugriff (PDF)

Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray

Blood, 2004-01, Vol.103 (1), p.275-282

2004

Volltextzugriff (PDF)

Transformation of follicular lymphoma to diffuse large B‐cell lymphoma proceeds by distinct oncogenic mechanisms

British journal of haematology, 2007-01, Vol.136 (2), p.286-293

2007

Volltextzugriff (PDF)

Cyclin D1–negative mantle cell lymphoma: a clinicopathologic study based on gene expression profiling

Blood, 2005-12, Vol.106 (13), p.4315-4321

2005

Volltextzugriff (PDF)

The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma

The New England journal of medicine, 2002-06, Vol.346 (25), p.1937-1947

2002

Volltextzugriff (PDF)

Systemic anaplastic large‐cell lymphoma: Results from the non‐Hodgkin's lymphoma classification project

American journal of hematology, 2001-07, Vol.67 (3), p.172-178

2001

Volltextzugriff (PDF)

Classification of non-Hodgkin lymphomas in Guatemala according to the World Health Organization system

Leukemia & lymphoma, 2011-09, Vol.52 (9), p.1681-1688

2011

Volltextzugriff (PDF)

Loss of major histocompatibility class II gene and protein expression in primary mediastinal large B-cell lymphoma is highly coordinated and related to poor patient survival

Blood, 2006-07, Vol.108 (1), p.311-318

2006

Volltextzugriff (PDF)

World Health Organization Classification of Neoplastic Diseases of the Hematopoietic and Lymphoid Tissues: Report of the Clinical Advisory Committee Meeting—Airlie House, Virginia, November 1997

Journal of clinical oncology, 1999-12, Vol.17 (12), p.3835-3849

1999

Volltextzugriff (PDF)

Prediction of Survival in Follicular Lymphoma Based on Molecular Features of Tumor-Infiltrating Immune Cells

The New England journal of medicine, 2004-11, Vol.351 (21), p.2159-2169

2004

Volltextzugriff (PDF)

Marginal Zone B-Cell Lymphoma: A Clinical Comparison of Nodal and Mucosa-Associated Lymphoid Tissue Types

Journal of clinical oncology, 1999-08, Vol.17 (8), p.2486-2492

1999

Volltextzugriff (PDF)

Mutations in the DNA-binding codons of TP53, which are associated with decreased expression of TRAILreceptor-2, predict for poor survival in diffuse large B-cell lymphoma

Blood, 2007-12, Vol.110 (13), p.4396-4405

2007

Volltextzugriff (PDF)

Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma

The Journal of experimental medicine, 2003-09, Vol.198 (6), p.851-862

2003

Volltextzugriff (PDF)

The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma

Cancer cell, 2003-02, Vol.3 (2), p.185-197

2003

Volltextzugriff (PDF)

The World Health Organization Classification of Hematological Malignancies Report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997

Modern pathology, 2000-02, Vol.13 (2), p.193-207

2000

Volltextzugriff (PDF)

Use of the World Health Organization (WHO) Classification of Non-Hodgkin's Lymphoma in Mumbai, India: A Review of 200 Consecutive Cases by a Panel of Five Expert Hematopathologists

Leukemia & lymphoma, 2004-08, Vol.45 (8), p.1569-1577

2004

Volltextzugriff (PDF)

Non-Hodgkin lymphoma in Chile: a review of 207 consecutive adult cases by a panel of five expert hematopathologists

Leukemia & lymphoma, 2012-07, Vol.53 (7), p.1311-1317

2012

Volltextzugriff (PDF)

Classification of Non-Hodgkin Lymphoma in Seven Geographic Regions Around the World: Review of 4539 Cases from the International Non-Hodgkin Lymphoma Classification Project

Blood, 2015-12, Vol.126 (23), p.1484-1484

2015

Volltextzugriff (PDF)

Mutations in the DNA-binding codons of TP53, which are associated with decreased expression of TRAIL receptor-2, predict for poor survival in diffuse large B-cell lymphoma

Blood, 2007-12, Vol.110 (13), p.4396-4405

2007

Volltextzugriff (PDF)

Reproducibility of a of thymic epithelial his togene t ic classification tumours

Histopathology, 1995-12, Vol.27 (6), p.589-589

1995

Volltextzugriff (PDF)

1 – 25 von 337

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(266)
Mit Volltextzugriff
(276)

Publikationsform

Artikel
(283)
Buchkapitel
(53)
Bücher
(1)

Sprache

Englisch
(284)
Deutsch
(54)
Japanisch
(54)

Erscheinungsjahr

n.n

Thema

Humans
(229)
Science & Technology
(202)
Life Sciences & Biomedicine
(201)
Biological And Medical Sciences
(155)
Medical Sciences
(148)
Female
(103)
Male
(101)
Hematologic And Hematopoietic Diseases
(85)
Pathology
(84)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(83)
Middle Aged
(83)
Adult
(77)
Aged
(69)
Oncology
(49)
Animals
(48)
Hematology
(47)
Immunohistochemistry
(47)
Adolescent
(37)
Tumors
(33)
Mice
(32)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

What is CD4+CD56+ malignancy and how should it be treated?

BCL2 Expression Is a Prognostic Marker for the Activated B-Cell–Like Type of Diffuse Large B-Cell Lymphoma

BCL2 Translocation Defines a Unique Tumor Subset within the Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma

Classification of non-Hodgkin lymphoma in Central and South America: a review of 1028 cases

Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray

Transformation of follicular lymphoma to diffuse large B‐cell lymphoma proceeds by distinct oncogenic mechanisms

Cyclin D1–negative mantle cell lymphoma: a clinicopathologic study based on gene expression profiling

The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma

Systemic anaplastic large‐cell lymphoma: Results from the non‐Hodgkin's lymphoma classification project

Classification of non-Hodgkin lymphomas in Guatemala according to the World Health Organization system

Loss of major histocompatibility class II gene and protein expression in primary mediastinal large B-cell lymphoma is highly coordinated and related to poor patient survival

World Health Organization Classification of Neoplastic Diseases of the Hematopoietic and Lymphoid Tissues: Report of the Clinical Advisory Committee Meeting—Airlie House, Virginia, November 1997

Prediction of Survival in Follicular Lymphoma Based on Molecular Features of Tumor-Infiltrating Immune Cells

Marginal Zone B-Cell Lymphoma: A Clinical Comparison of Nodal and Mucosa-Associated Lymphoid Tissue Types

Mutations in the DNA-binding codons of TP53, which are associated with decreased expression of TRAILreceptor-2, predict for poor survival in diffuse large B-cell lymphoma

Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma

The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma

Loss of MHC class II gene and protein expression in diffuse large B-cell lymphoma is related to decreased tumor immunosurveillance and poor patient survival regardless of other prognostic factors: a follow-up study from the Leukemia and Lymphoma Molecular Profiling Project

The World Health Organization Classification of Hematological Malignancies Report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997

Use of the World Health Organization (WHO) Classification of Non-Hodgkin's Lymphoma in Mumbai, India: A Review of 200 Consecutive Cases by a Panel of Five Expert Hematopathologists

Non-Hodgkin lymphoma in Chile: a review of 207 consecutive adult cases by a panel of five expert hematopathologists

Loss of major histocompatibility class II expression in non-immune-privileged site diffuse large B-cell lymphoma is highly coordinated and not due to chromosomal deletions

Classification of Non-Hodgkin Lymphoma in Seven Geographic Regions Around the World: Review of 4539 Cases from the International Non-Hodgkin Lymphoma Classification Project

Mutations in the DNA-binding codons of TP53, which are associated with decreased expression of TRAIL receptor-2, predict for poor survival in diffuse large B-cell lymphoma

Reproducibility of a of thymic epithelial his togene t ic classification tumours

Suchergebnisse filtern